update from section chief
medical oncology
Roy S. Herbst, MD, PhD
barbara burtness, md
T
he Section of Medical Oncology has 100+ full-time faculty focused on advancing
therapy from the lab to the clinic and back. The section is led by Section Chief Roy S. Herbst, MD, PhD, and Clinical Chief Harriet Kluger, MD. Patient Care / Clinical Services The Section of Medical Oncology had to adapt its locations to care for COVID-19 patients, relocating some patients from Smilow Cancer Hospital’s York Street Campus to Yale New Haven Hospital’s Saint Raphael Campus. Care was also relocated from New Haven to North Haven Medical Center.
62
annual report 2021
The section works within the following disease-aligned research teams (DARTs) of breast, gastroenterology, genitourinary, head & neck, melanoma, Phase I trials, and thoracic. Clinical volume continues to grow at Smilow’s main campus and across the care centers. Yale’s medical oncologists care for patients across Smilow Care Centers across Connecticut and Rhode Island. In
total, the section’s faculty provides patient care at 15 practice sites, and is committed to offering patients innovative clinical care that stems from laboratory science into treatment options, delivered with compassion at their local care site. In March 2020, new North Pavilion 12 firm chiefs were named: Paul Eder, MD (Education and Oncology Practice); and Elizabeth Prsic, MD (Operations and Quality). In June 2021, Sarah
